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Abstract An intervention that can prevent low back pain
(LBP) becoming chronic, may not only prevent great dis-
comfort for patients, but also save substantial costs for the
society. Psychosocial factors appear to be of importance in
the transition of acute to chronic LBP. The aim of this
study was to compare the cost-effectiveness of an inter-
vention aimed at psychosocial factors to usual care in pa-
tients with (sub)acute LBP. The study design was an
economic evaluation alongside a cluster-randomized con-
trolled trial, conducted from a societal perspective with a
follow-up of 1 year. Sixty general practitioners in 41
general practices recruited 314 patients with non-specific
LBP of less than 12 weeks’ duration. General practitioners
in the minimal intervention strategy (MIS) group explored
and discussed psychosocial prognostic factors. Usual care
(UC) was not protocolized. Clinical outcomes were func-
tional disability (Roland–Morris Disability Questionnaire),
perceived recovery and health-related quality of life (Eu-
roQol). Cost data consisted of direct and indirect costs and
were measured by patient cost diaries and general practi-
tioner registration forms. Complete cost data were avail-
able for 80% of the patients. Differences in clinical
outcomes between both the groups were small and not
statistically significant. Differences in cost data were in
favor of MIS. However, the complete case analysis and the
sensitivity analyses with imputed cost data were inconsis-
tent with regard to the statistical significance of this dif-
ference in cost data. This study presents conflicting points
of view regarding the cost-effectiveness of MIS. We con-
clude that (Dutch) general practitioners, as yet, should not
replace their usual care by this new intervention.
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Introduction
Low back pain (LBP) affects a large number of people each
year. Lifetime prevalence rates range from 49 to 70% [45].
LBP causes not only great discomfort, but also great eco-
nomic loss due to work absenteeism [28, 45]. In the UK,
LBP is one of the most expensive conditions for which an
economic analysis has been carried out [28]. Economic
evaluations in which both the costs and clinical outcomes
of two or more interventions are compared, are becoming
increasingly important, as health care expenditures rise
while budgets remain limited [44]. The importance of
economic evaluations is illustrated by the fact that some
authors suggest that an intervention might be implemented
when it is less effective but saves substantial costs [8].
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As especially chronic LBP is associated with substantial
costs to society [15], a large amount of costs can be saved
by interventions that prevent acute LBP becoming chronic.
The rationale is that it will be more cost-effective to ad-
dress a wider target population early with simple low-cost
interventions than to expend considerable time and re-
sources on rehabilitating the smaller group of back pain
patients who have become incapacitated by chronic pain.
As psychosocial factors have been shown to play an
important role in the transition from acute to chronic back
pain [25, 33], one may assume that early interventions
focusing on these factors prevent chronicity.
We tested this assumption by conducting a cluster-ran-
domized clinical trial in general practice, comparing a
minimal intervention strategy (MIS) aimed at psychosocial
factors for patients with (sub)acute LBP to usual care (UC)
by the GP, which was not standardized. Our theory on the
working mechanisms of MIS was that identification and
discussion of psychosocial factors would lead to modifi-
cation of these factors, eventually leading to better func-
tioning. Unfortunately, MIS appeared to be no more
effective than UC in improving the following clinical
outcomes: the degree of functional disability, the recovery
rate and the number of patients on sick-leave due to LBP
[20]. These findings are in line with Linton and Andersson
[26], who showed that their cognitive-behavioral inter-
vention was not more effective than usual care in reducing
the degree of back pain and generic function status.
However, their intervention was effective in reducing the
number of visits to a physician for spinal pain and number
of days of sick-leave, implicating time savings for physi-
cians and thus substantial cost savings for society. These
results may indicate an increase in coping or self-care with
the pain; patients who received the psychosocial interven-
tion, less often visited a physician and had less days of
work while they had the same degree of functional dis-
ability as the patients who received usual care. These
promising results, in combination with the fact that self-
care with the pain was also a goal in our MIS, the recent
emphasis on health care budgets, and the call for more high
quality economic evaluations on the cost-effectiveness of
treatments for LBP [43] stimulated us to conduct an eco-
nomic evaluation from a societal perspective with a follow-
up of 1 year. We hypothesized that MIS would be cost-
effective compared to UC.
Materials and methods
Study design
The study is designed as a full economic evaluation
alongside a cluster-randomized controlled trial and was
approved by the Medical Ethics Committee of the VU
University Medical Center in Amsterdam, the Netherlands.
Randomization and training sessions
Randomization took place at the level of the general
practice in blocks of four practices, according to a random
numbers table prepared before recruitment of general
practitioners. General practitioners were informed about
their allocation after they had given final consent to par-
ticipation. Twenty practices (28 GPs) were randomized to
the MIS group and 21 practices (32 GPs) to the UC group.
The GPs randomized to the MIS group received two
training sessions of 2.5 h each which were given by a GP
(HvdH) with extensive expertise in development and
training of psychosocial interventions. The training con-
sisted of theory, role-playing and feedback on the practiced
skills. In addition, a treatment manual was provided. The
contents of the training sessions and its evaluation by GPs
have been described in more detail elsewhere [21].
Patients and interventions
Participating GPs were asked to select ten consecutive
patients who consulted them for LBP. Inclusion criteria
were age 18–65, non-specific LBP of less than 12 weeks’
duration (i.e. (sub)acute LBP) or an exacerbation of mild
symptoms, and sufficient knowledge of the Dutch lan-
guage. Exclusion criteria were specific LBP (i.e. LBP
caused by specific pathological conditions), LBP currently
treated by another healthcare professional, and pregnancy.
Patients, but not their GPs, were kept unaware that two
different interventions were studied.
Patients received a minimal intervention strategy (MIS)
or usual care (UC). The MIS was aimed at identification
and discussion of psychosocial prognostic factors. The MIS
consultation lasted about 20 min and consisted of three
phases: exploration, information and self care. During the
exploration phase, the GP explored the presence of psy-
chosocial prognostic factors by asking standardized ques-
tions that could be rephrased to fit the style of
communication of the doctor and the patient. The follow-
ing psychosocial prognostic factors were explored: the
patient’s own ideas on the cause of their LBP, fear
avoidance beliefs, worries/distress, pain catastrophising,
pain behaviors and reactions from the social environment
(family, friends, work). In the information phase the GP
provided general information on the cause, course and
(im)possibilities of treatment of LBP, thereby giving spe-
cific attention to psychosocial factors identified in the
exploration phase. Finally, in the self care phase, the GP
and patient set specific goals on resuming activities or
work. Follow-up consultations were not protocolized, but
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we advised GPs to make an appointment for a follow-up
visit in case they identified obstacles to recovery and sus-
pected an increased risk of chronic LBP.
GPs in the UC group provided care as usual. We did not
protocolize the content and number of UC consultations,
and assumed that GPs would generally follow the guideline
for LBP of the Dutch College of General Practitioners [13].
For acute LBP (<6 weeks’ duration) this guideline advises
a wait and see policy. For subacute LBP (6–12 weeks’
duration) the guideline advises referral for physical therapy
in the case of persistent functional disability. Explicit
guidance on psychosocial factors is lacking. The contents
of both interventions have been described in more detail
elsewhere [20].
Data collection
Clinical outcomes
Baseline data were collected during a home visit by a re-
search assistant, while follow-up data after 12 months were
collected using postal questionnaires. Primary clinical out-
come measures were functional disability, perceived
recovery, and health related quality of life. Functional dis-
ability was measured at baseline and after 12 months by the
Roland–Morris disability questionnaire (0–24) [35]. Per-
ceived recovery was scored by the patient on a 7-point
Likert scale (very much/much/slightly improved, no
change, slightly/much/very much worse) after 12 months
[42]. As a score of at least ‘‘much improved’’ has been
denoted a minimal clinically important change [32], pa-
tients were a priori defined as recovered if they reported at
least ‘‘much improvement’’. Health related quality of life
was measured at baseline and after 3, 6 and 12 months by
the EuroQol (0–1) [12], covering five domains: mobility,
self-care, usual activities, pain/discomfort, and anxiety/
depression. The EuroQol scores were transformed into
utilities using a representative British sample and time
trade-off methods. The utilities were then multiplied by the
amount of time a patient spent in this particular health state,
with transitions between health states linearly interpolated
[7]. This results in quality adjusted life years (QALYs).
In order to describe the study population characteristics
in more detail and to compare baseline similarity of both
intervention groups, five other outcome measures were as-
sessed at baseline: (1) pain severity during the day (0–10)
[27]; (2) perceived general health (1–5), using the first
question of the subscale ‘‘general health perceptions’’ of the
short form health survey (SF-36) [47]; (3) fear avoidance
beliefs, using the 4-item physical activity subscale of the
fear avoidance beliefs questionnaire (FABQ, 0–24) [46]; (4)
catastrophising thoughts, using the 6-item subscale of the
coping strategies questionnaire (CSQ, 0–36) [36] and (5)
distress, measured by the 16-item subscale of the four-
dimensional symptom questionnaire (4DSQ, 0–32) [37].
Cost data
The economic evaluation was conducted from a societal
perspective, indicating that all costs and consequences of
the competing interventions are taken into account
regardless of who pays for or benefits from them [9]. A
societal perspective incorporates direct health care costs,
direct non-health care costs and indirect costs due to LBP.
All cost data were collected by prospective cost diaries [16]
that patients completed for the periods baseline to
3 months, 3–6 months, 6–9 months, and 9–12 months. In
addition, GPs were contacted after 12 months follow-up to
provide information on follow-up consultations due to LBP
in the last year (date, referrals, medication prescribed by
physician). GPs used their medical records to complete
these registration forms.
Table 1 summarizes the cost categories, and the prices
and sources used for valuing. ‘‘Medication’’ in Table 1
includes both the over-the-counter medication and medi-
cation prescribed by physicians, while self-prescribed
alternative interventions are included in ‘‘complementary
care’’. Costs of absenteeism from paid labor due to LBP
were calculated according to the friction cost approach
[23]. This approach is based on a mean income of the
Dutch population according to age and gender, and defines
a friction period as 154 days [31]. As most cost data were
collected during the year 2002, prices were adjusted using
consumer price index figures.
Statistical analysis
Firstly, baseline similarity was studied. Secondly, we
compared baseline characteristics of patients with complete
cost data to those with incomplete cost data by using lo-
gistic regression analysis. Thirdly, clinical outcomes and
total costs were compared. As cost data are characterized
by large variation and irregular distributions and as a
complete cost dataset was available for 80% of our par-
ticipants (250/314), we decided that our primary analysis
would be a complete case analysis. Differences between
groups (MIS minus UC) were calculated for the clinical
outcomes: (1) functional disability, by calculating change
scores between baseline and 12 months follow-up; (2)
perceived recovery at 12 months follow-up; and (3) health-
related quality of life gained over 12 months (i.e. QALYs).
Students t tests were used to analyze the change scores
between the treatment groups for functional disability and
quality of life, and a Chi-square test for perceived recovery.
To compare costs between the two groups, confidence
intervals (CIs) for the mean differences in costs were cal-
1814 Eur Spine J (2007) 16:1812–1821
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culated using bias-corrected and accelerated bootstrapping
(2000 replications) [11]. Bootstrapping incorporates
drawing samples with replacement and is a preferred
method for the analysis of cost data, as it uses the observed
distributions of the data without making assumptions about
the shape of the distribution [38]. Fourthly, cost-effec-
tiveness analyses were performed. Incremental cost-effec-
tiveness ratios were calculated in which the mean
difference in total costs (MIS minus UC) was divided by
the mean difference in improvement on the clinical out-
comes (MIS minus UC). Uncertainty around the ratios was
calculated using the bias-corrected percentile bootstrapping
method (5,000 replications) [5] and plotted on a cost-
effectiveness plane.
Sensitivity analyses
A complete case analysis has some disadvantages. Due to
the missing data the power of the analysis is reduced and
bias may be introduced due to selective drop-out. Imputa-
tion can be used to replace missing data by statistical esti-
mates of the missing values. To explore the robustness of
our primary analysis, we performed two sensitivity analyses
in which we imputed missing data: in one analysis we im-
puted all missing cost data, and in the other we imputed only
missing days of absenteeism. Imputation was done using the
Expectation Maximization algorithm (SPSS 10.1).
Results
Between September 2001 and April 2003, 314 patients
were enrolled in our study: 143 in the MIS group and 171
in the UC group. Table 2 shows that baseline characteris-
tics of GPs and patients were largely similar for the two
groups. Less than 9% of all patients withdrew from the
study during follow-up. Reasons were ‘no time and no
complaints anymore’ (MIS n = 1, UC n = 4), ‘‘burden too
high due to psychological problems’’ (UC n = 3) or ‘‘un-
known’’ (MIS n = 10; UC n = 8). The flow chart of this
study, including information on refusals, exclusions and
drop-outs has been published in our previous paper [20].
For 116 patients (81%) in the MIS group and 134 pa-
tients (78%) in the UC group complete cost data were
available. Logistic regression analysis comparing baseline
characteristics of patients with complete cost data to those
with incomplete cost data showed that patients with
incomplete cost data on average were younger and scored
higher on distress at baseline.
Clinical outcomes
After 1 year follow-up both the groups showed similar
improvements in clinical outcomes. Sixty-nine percent of
the patients were defined as recovered after 1 year. The
difference between both the groups in mean improvement
on functional disability was –0.74 points on the RDQ (95%
CI, –2.31 to 0.83), and –2% (95% CI, –14 to 10%) on
recovery rate. Over the follow-up period of 1 year the
mean difference in quality of life was 0.004 QALYs (95%
CI, –0.04 to 0.03). All differences favored UC, but were
neither clinically relevant nor statistically significant
(Table 5).
Table 1 Prices used for valuing resources (year 2002)
Resources Euro
Direct health care
Primary care costs
General practitioner (consultation)a 19.8
MIS-consultation, including intervention costs
(consultation)b
40.9
Physical therapist (treatment session)a 22.3
Manual therapist (treatment session)c 30.8
Exercise therapist (treatment session)a 22.5
Back school (treatment session) [18] 66.3
Chiropractor (treatment session)d 40.0
Physiofitness (treatment program, 10 sessions)b 120.0
Professional homecare (per hour)a 21.3
Psychologist (treatment session)d 75.0
Secondary care costs
Outpatient appointmenta 54.8
Hospitalization general hospital (per day)a 330.0
Surgery (per hour)b 884.7
Radiographb 48.2
MRI-scanb 212.9
Medication e
Direct non-health care
Complementary care d
Informal care (per hour)a 8.1
Equipment aids f
Indirect costs
Absenteeism from paid work g
Absenteeism from unpaid worka 8.1
MIS Minimal intervention strategy, MRI Magnetic resonance imaging
a Price according to Dutch guidelines [30]
b Calculated unit costs
c Price according Dutch Central Organisation for Health Care
Charges [10]
d Price according to professional organisation or health care provider
e Price of medication prescribed by the GP according to Royal Dutch
Society for Pharmacy [48]; price of over-the-counter medication
according to cost diaries
f Price according to cost diaries
g Costs based on mean income of Dutch population according to age
and sex [23, 31]
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Cost data
Table 3 lists per patient the mean utilization of resources
(i.e. health care, help, absenteeism). In both the groups,
resource utilization was low and largely similar. Only two
statistically significant differences were found. In the year
following randomization patients in the MIS group had more
consultations with a GP (MIS 2.7 vs. UC 0.9), excluding
the consultation leading to recruitment but including the
20 min consultation aimed at psychosocial measures as
specified by the study protocol. Patients in the UC group
reported more consultations with a manual therapist (MIS
0.1 vs. UC 0.4) but the proportions of patients who received
such a treatment (MIS 2.6% vs. UC 9%) were very low.
Table 2 Baseline
characteristics of general
practitioners and patients
GP General practitioner, MIS
Minimal intervention strategy,
UC Usual care, n number, SD
Standard deviation, IQR Inter
quartile range (25th–75th
percentile), LBP Low back pain,
RDQ Roland–Morris disability
Questionnaire, SF-36 Short-
form 36, FABQ Fear avoidance
and beliefs questionnaire, CSQ
Coping strategies questionnaire,
4DSQ 4D symptom
questionnaire (higher scores
means more functional
disability, worse health, more
fear-avoidance, more
catastrophising or more distress)
a Two missing values
b One missing value
MIS UC
GPs n = 28 n = 32
Demographic characteristics
Age (years)a, mean (SD) 43.0 (7.2) 45.7 (7.4)
Gender, female 6/28 12/32
Number of included patients per GP
0 1/28 5/32
1–5 17/28 14/32
>5 10/28 13/32
Patients n = 143 n = 171
Demographic characteristics
Age (years), mean (SD) 43.4 (11.1) 42.0 (12.0)
Gender, % female 47.6 47.4
Nationality, % Dutch 97.2 97.7
Health insurance, % public 70.6 67.8
Educational level and work status
Education levela, %
Primary 35.0 33.1
Secondary 46.2 52.7
College, university 18.8 14.2
Paid job, % yes 81.8 81.3
Sick leave because of LBPa (among the working population), % yes 34.8 41.0
Characteristics of LBP
Duration current episode (days), median (IQR) 11 (5–21) 14 (7–21)
Frequency of LBP episodes last year, %
1 or 2 episodes 58.0 60.8
3 or more episodes 19.6 18.7
Exacerbation of persisting LBP 22.4 20.5
Pain radiating below kneea, % 12.8 14.6
Clinical outcomes, primary measures
Functional disability (RDQ, 0–24), mean (SD) 11.7 (5.4) 12.2 (5.0)
Health related quality of life (EuroQol), mean (SD) 0.61 (0.25) 0.61 (0.24)
Clinical outcomes, secondary measures
Pain severity during the day (0–10)b, mean (SD) 4.9 (2.0) 4.8 (2.0)
Severity of the main complaint (0–10)a, mean (SD) 7.0 (1.9) 6.8 (2.0)
Perceived general health (SF-36, 1–5)a, mean (SD) 2.7 (0.8) 2.8 (0.8)
Clinical outcomes, psychosocial measures
Fear-avoidance beliefs (FABQ, 0–24), mean (SD) 14.3 (5.6) 15.3 (5.2)
Catastrophising thoughts (CSQ, 0–36), mean (SD) 10.3 (6.6) 11.2 (6.9)
Distress (4DSQ, 0–32)b, mean (SD) 8.3 (7.0) 9.5 (7.3)
1816 Eur Spine J (2007) 16:1812–1821
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Table 4 shows the mean total costs in both the treatment
groups and the difference in costs with 95% CI. Total
indirect costs, especially absenteeism from paid work, were
the largest contributor to the total costs. The difference in
total costs amounted to 490 e (95% CI –987 to 92 e) in
favor of the MIS group (MIS 799 e; UC 1288 e), but this
difference was not statistically significant.
Cost-effectiveness
Table 5 shows the incremental cost-effectiveness ratios
(ICERs) for the three outcome measures. MIS resulted in
less improvement than UC, but saved money. The ICER
for functioning was 690 e, indicating that per point less
improvement on the RDQ MIS saved 690 e, while per
percent less improvement in recovery rate MIS saved
239 e. The difference in QALY’s gained during 1 year
between both the groups was very small, resulting in a
large ICER of 47,348 e. The large majority of the
bootstrapped ICERs presented on the cost-effectiveness
planes are located in the southern quadrants (Fig. 1),
indicating that the costs of MIS were lower than the
costs of UC.
Sensitivity analyses
Imputation of missing cost data led to a mean difference of
–628 e (95% CI –1123 to –81 e) in total costs. Imputation
of missing data on days of absenteeism led to a mean
difference of –545 e (95% CI –1031 to –40 e) in total
costs. Both differences are statistically significant and in
favor of MIS.
Table 3 Mean resource use
(SD) per patient (n = 250) for
MIS and UC during 12 months
follow-up, and the percentage of
patients who made use of that
specific resource
*Significant difference
(P \ 0.05)
SD Standard deviation, n
number, MIS Minimal
intervention strategy, UC Usual
care
Resources MIS (n = 116) UC (n = 134)
Direct health care
Primary care
General practitioner (consultations)* 2.7 (1.0) 99.1% 0.9 (1.2) 44%
Physical therapy (treatment sessions) 2.3 (5.8) 17.2% 3.2 (5.8) 35.1%
Manual therapy (treatment sessions)* 0.1 (0.7) 2.6% 0.4 (1.7) 9%
Exercise therapy (treatment sessions) 0.3 (1.8) 2.6% 0.9 (3.5) 9%
Back school (treatment sessions) 0.5 (0.6) 0.9% 0 (0) 0%
Chiropractor (treatment sessions) 0 (0) 0% 0.1 (0.9) 2.2%
Physiofitness (treatment programs) 0.1 (0.2) 6% 0.1 (0.2) 4.5%
Professional home care (hours) 0 (0) 0% 0.6 (6.5) 0.7%
Psychologist (treatment sessions) 0.1 (0.8) 0.9% 0 (0) 0%
Secondary care
Outpatient visit (number) 0.1 (0.4) 4.3% 0.2 (0.7) 7.5%
Hospitalization (days) 0.02 (0.2) 0.9% 0.01 (0.1) 0.7%
X-ray (number) 0.1 (0.3) 5.2% 0.1 (0.4) 9.7%
MRI-scan (number) 0.01 (0.1) 0.9% 0.03 (0.2) 2.2%
Medication (% yes) – 74.1% – 73.9%
Direct non-health care
Complementary care
Homeopathy (treatment sessions) 0.04 (0.3) 1.7% 0 (0) 0%
Osteopathy (treatment sessions) 0.1 (0.5) 3.4% 0.2 (0.3) 0.7%
Massage (treatment sessions) 0.1 (0.8) 1.7% 0.4 (3.0) 3.7%
Acupuncture (treatment sessions) 0 (0) 0% 0.04 (0.4) 1.5%
Magnetizer (treatment sessions) 0.3 (2.3) 1.7% 0.1 (1.0) 0.7%
Orthomanual therapy (treatment sessions) 0.03 (0.3) 1.7% 0.03 (0.4) 0.7%
Podiatrist 0.03 (0.2) 1.7% 0.03 (0.3) 1.5%
Informal care (hours) 0 (0) 0% 0.7 (6.3) 3%
Equipment aids (% yes) – 10.3% – 6.0%
Indirect costs
Absenteeism paid work (days) 4.2 (12.1) 28.4% 8.6 (23.1) 38.8%
Absenteeism unpaid work (hours) 2.2 (10.9) 12.1% 3.3 (10.4) 17.2%
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Discussion
The results of our primary analysis showed no statistically
significant differences in total costs or clinical outcomes
between our psychosocial intervention and UC in patients
with (sub)acute LBP in general practice. However, the
results of our sensitivity analyses are inconsistent with
those of the primary analysis. In this discussion section we
will focus on the interpretation of our cost data and the
methodological issues involved when interpreting cost
data. In previous papers we have discussed several meth-
odological issues involved when interpreting the clinical
outcomes (e.g. the quality of the training sessions and
interventions) [20, 21].
Comparison to the literature
A recent review on the cost-effectiveness of treatments for
patients with LBP reported that 6 of the 17 studies
concluded that the intervention of interest was more
cost-effective than the control intervention [43]. Unfortu-
nately, no definite conclusions for the cost-effectiveness of
a specific intervention could be given as the number of
economic evaluations per type of intervention was limited.
More recently the cost-effectiveness analyses of two trials
on psychosocial primary care interventions for LBP have
been published. The UK BEAM Trial compared spinal
manipulation, exercise classes incorporating cognitive
behavioral principles, spinal manipulation plus exercise
classes, and best care [40, 41]. Although the authors con-
clude that spinal manipulation is a cost-effective addition
to ‘‘best care’’, as it generates 0.04 more QALYs for an
extra 279 e [37], others question this conclusion [6, 39].
Another study in primary care compared advice directed
towards promoting self-management and modifying beliefs
and behavior, and routine physiotherapy treatment with
advice only [14, 34]. The authors conclude that advice
should be considered as the first-line treatment, as out-
of-pocket expenses of patients receiving routine physio-
therapy were significantly higher (41£, 59 e), while
differences in either QALYs (0.02) or National Health
Service costs (20£, 29 e) were not significantly different
Table 4 Mean costs (SD) in
Euros per patient in the MIS and
UC group and differences
between both the groups during
follow-up of 52 weeks
None of the mean differences
between MIS and UC are
statistically significant
(P > 0.05)
SD Standard deviation, MIS
Minimal intervention strategy,
UC Usual care, n Number, 95%
CI 95% confidence interval
MIS (n = 116) UC (n = 134) Mean difference
(95% CI)
Direct health care costs 181 (287) 175 (275) 6 (–65; 73)
Primary care costs 159 (181) 152 (242) 7 (–52; 54)
Secondary care costs 22 (179) 23 (101) –1 (–44; 35)
Medication costs 9 (18) 9 (14) 0 (–4; 4)
Direct non-health care costs 30 (75) 31 (129) –1 (–25 ; 27)
Complementary care costs 18 (65) 21 (115) –2 (–24; 22)
Informal care 6 (34) 8 (58) –2 (–12; 11)
Equipment aids 5 (22) 2 (14) 3 (–2; 6)
Indirect costs 587 (1,636) 1,081 (2,463) –495 (–921; 158)
Absenteeism paid work 569 (1,631) 1,055 (2,448) –486 (–932; 50)
Absenteeism unpaid work 18 (89) 27 (84) –9 (–31; 18)
Total costs 798 (1,820) 1,288 (2,594) –490 (–987; 92)
Table 5 Incremental cost-effectiveness ratios for functional disability, perceived recovery and health-related quality of life
Outcome measure MIS UC MIS versus UC
Costs Effectsa Costs Effectsa ICER
Functional disability (RDQ; 0–24)
Change score between baseline
and 1 year follow-up
798 e
(n = 116)
8.378
(n = 116)
1,307 e
(n = 132)
9.116
(n = 132)
MIS results in less improvement,
but saves 690 e per RDQ point
Recovery rate Score at
1 year follow-up
798 e
(n = 116)
68.1%
(n = 116)
1,288 e
(n = 134)
70.1%
(n = 134)
MIS results in less improvement,
but saves 239 e per 1%
Quality of life
(EuroQol; QALY)
Score over 1 year follow-up
819 e
(n = 102)
0.833
(n = 102)
1030 e
(n = 111)
0.837
(n = 111)
MIS results in less improvement,
but saves 47,348 e per QALY
MIS Minimal intervention strategy, UC Usual care, ICER Incremental cost-effectiveness ratio, n Number, QALY Quality adjusted life year
a Difference in clinical outcomes between baseline and 12 months follow-up
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[34]. Both the above mentioned studies found lower QA-
LYs and higher health care costs over 12 months than we
found in our study. The shorter duration of the LBP episode
at baseline of our patients and, thus, their more favorable
prognosis may (partly) explain these results. In contrast to
our study, both the trials did not include indirect costs in
their cost-effectiveness analyses, even though it is gener-
ally agreed upon that indirect costs associated with work
absence due to LBP account for high economic costs in
western societies [28, 45].
Methodological issues and secondary analyses
In our study, we used the British sample as reference
population for the utilities as, until recently, these were
the only reference data available in the Netherlands. Re-
cently, a EuroQol transformation has been introduced
based on a Dutch sample [24]. We decided not to use this
Dutch transformation as (1) it has only been internally
validated through bootstrapping methods but not yet
externally validated; (2) the representativeness of the,
rather small (n = 298), Dutch sample can be debated [4]
and, finally (3) use of the Dutch transformation would
complicate comparison across international studies. A
comparison between the use of a Dutch or UK sample
showed that, although QALYs based on the Dutch sample
were slightly higher compared to the British sample, the
mean differences between the groups, in this case two
primary care interventions for treatment of depression,
were largely the same [2].
We based our sample size calculations on demonstrating
a clinically relevant difference of 2.5 points on the RDQ
instead of demonstrating the cost-effectiveness [20]. Al-
though the usefulness of sample size calculations in eco-
nomic evaluations has been debated [1], the required
sample size in an appropriately powered cost-effectiveness
study is expected to be much larger than in a clinical
effectiveness trial [3].
Work absence due to LBP was the main contributor to
the total costs associated with LBP. The number of days of
absenteeism was twice as high in the UC group as in the
MIS group. Although not statistically significant, this
finding induced us to explore whether MIS was cost-
effective among patients having a paid job (n = 93 MIS;
n = 110 UC). This post-hoc subgroup analysis showed that
the difference in total costs amounted to –548 e (95% CI –
1137 to 200 e) in favor of MIS, which was not statistically
significant. As this subgroup analysis was clearly insuffi-
ciently powered, and as other early interventions have been
shown to reduce sick-leave in workers [17, 19, 22] one may
hypothesize that MIS may be cost-effective in an occupa-
tional setting. The sensitivity analyses with imputed data
were less underpowered and, interestingly, showed statis-
tically significant differences in total costs between groups.
The question now arises which analysis we should value
most.
Interpretation of the conflicting results
A complete case analysis has the advantage over an im-
puted analysis that no assumptions have to be made
regarding imputation of data that are characterized by large
variation and irregular distributions. However, a complete
case analysis does not include all participating patients,
which reduces the statistical power and which may intro-
duce bias. Advocates of the (conclusions of our) complete
case analysis may, among others, be (1) researchers who do
not favor imputation techniques when data are available for
80% of the cases; (2) GPs, as application of MIS will in-
crease their workload, with no evidence of improvement of
the patients’ functional disability, recovery rates, or pain
intensity. Advocates of the (conclusions of our) sensitivity
analysis may among others be (1) researchers who favor
imputation techniques; (2) policy makers, who are inter-
ested in all relevant costs and effects regardless of who will
pay the costs and who may benefit; or (3) managers in
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workplace settings as they may be especially interested in
the reduction of costs due to sick-leave.
The cost-effectiveness planes do not provide a solution
for the impasse. The plane for functional disability showed
that 96% of the bootstrapped cost-effect pairs, although
very close to the origin of the plane, were located in the
southern quadrants. Does this indicate cost-effectiveness of
MIS? The answer to this question will depend on the way
one defines cost-effectiveness. Obviously, when a new
intervention is clinically more effective and less costly than
the old intervention (south–east quadrant), there will be no
debate about cost-effectiveness and implementation of the
new intervention. When a new intervention is clinically
more effective and more costly (north-east quadrant), a
new intervention will be considered cost-effective when
costs stay below a certain threshold. Dowie (2004) [8],
however, questions why an intervention should not also be
implemented when it is less effective but does save sub-
stantial costs, pleading for defining a threshold that extends
into the south-west quadrant. This threshold can be a
straight line from the north-east to the south-west quadrant,
or kinked at the origin of the cost-effectiveness plane,
indicating that the selling price for an unit of effect is
greater than the buying price of an additional unit of effect
[29].
Although there are various points of view, we conclude
that (Dutch) GPs should not replace their UC by MIS in
patients with (sub)acute LBP. This conclusion is based on
the results of the complete case analysis, because this was
our pre-planned analysis. The second reason is that the
difference in costs, if any, was mainly caused by a small
proportion of the population who reported sick leave due to
back pain. We cannot rule out the possibility that this was a
chance finding. The third reason is that MIS is a new
approach in general practice. Implementation of MIS will
meet many difficulties, given the lack of evidence for
clinical effects, the need for training of GPs and the in-
crease of GP workload. The final, and maybe most
important reason is that our study is the first and, as far as
we know, the only study that investigated the cost-effec-
tiveness of a psychosocial intervention in patients with
(sub)acute LBP in general practice.
Conclusions
Results of only one study are insufficient to establish firm
evidence on the cost-effectiveness of an intervention. More
studies on the cost-effectiveness of psychosocial interven-
tions in general practice are needed, thereby taking into
account some of the factors that may explain why our
intervention was not more successful than usual GP care as
described in previous papers [20, 21]. As yet, we conclude
that (Dutch) general practitioners should not replace their
usual care by our new intervention.
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